This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on April 29, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
NOI - Olink Explore HT Proteomic Analysis for Sickle Cell Disease Study
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Heart, Lung, and Blood Institute (NHLBI) plans to award a non-competitive purchase order for high-throughput proteomic analysis services utilizing the Olink Explore HT platform. This contract supports a longitudinal study focused on understanding the role of transthyretin (TTR) variants in the severity of sickle cell disease. The services required include standardized sample processing, assay execution, quality control, and delivery of normalized datasets compatible with previously generated study data, with the analysis covering quantification of over 5,400 proteins per sample. This announcement serves as a Notice of Intent for the upcoming non-competitive award, although interested parties may submit capability statements to demonstrate their qualifications to meet the government’s requirements. The solicitation, identified as 75N98026Q00281, was posted on April 29, 2026, with a response deadline set for May 13, 2026. The contract falls under NAICS code 541380, and the work will be performed in Rockville, Maryland, with the primary point of contact being Nicholas S. Capobianco at the National Institutes of Health.
General Info
Agency
NAICS
Place of Performance
Rockville, MD, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
The National Heart, Lung, and Blood Institute (NHLBI) intends to award a non-competitive purchase order for high-throughput proteomic analysis services using the Olink Explore HT platform. The requirement supports a longitudinal study investigating transthyretin (TTR) variants in sickle cell disease severity and includes quantification of over 5,400 proteins per sample. Services include standardized sample processing, assay execution, quality control, and delivery of normalized datasets compatible with previously generated study data. This notice is issued as a Notice of Intent for a non-competitive award; however, interested parties may submit capability statements demonstrating their ability to meet the Government’s requirement.
